BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32130615)

  • 21. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fertility preservation in ovarian cancer patients.
    Santos ML; Pais AS; Almeida Santos T
    Gynecol Endocrinol; 2021 Jun; 37(6):483-489. PubMed ID: 33501866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
    Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
    Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
    Cakmak H; Katz A; Cedars MI; Rosen MP
    Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A patient with a mucinous borderline ovarian tumor after fertility-sparing surgery in whom puncture fluid cytology on oocyte retrieval led to a diagnosis of recurrence.
    Yoshiba T; Takei Y; Manaka Y; Suzuki T; Fujiwara H
    J Obstet Gynaecol Res; 2022 Oct; 48(10):2635-2639. PubMed ID: 35871537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.
    Walker Z; Lanes A; Ginsburg E
    Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
    Wang P; Fang L
    World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fertility preservation in childhood and adolescent female tumor survivors.
    Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
    Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Unilateral borderline ovarian tumor and unilateral adenexectomy?].
    Boujenah J; Bricou A; Moreaux G; Grynberg M; Sifer C; Hugues JN; Poncelet C
    Gynecol Obstet Fertil; 2014 Sep; 42(9):635-9. PubMed ID: 25164163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancer.
    Pereira N; Hubschmann AG; Lekovich JP; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Aug; 108(2):357-360. PubMed ID: 28629583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
    Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
    Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation.
    Bercaire LMN; Cavagna M; Donadio NF; Rocha AR; Portela R; Alves VR; Santos TBB; Cavagna F; Dzik A; Gebrim LH; Nahas EAP
    JBRA Assist Reprod; 2020 Jul; 24(3):257-264. PubMed ID: 32293820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Counseling young women with early breast cancer on fertility preservation.
    Ter Welle-Butalid MEE; Vriens IJHI; Derhaag JGJ; Leter EME; de Die-Smulders CEC; Smidt MM; van Golde RJTR; Tjan-Heijnen VCGV
    J Assist Reprod Genet; 2019 Dec; 36(12):2593-2604. PubMed ID: 31760547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian stimulation for oocyte cryopreservation for prevention of age-related fertility loss: one in five is a low responder.
    Tsafrir A; Haimov-Kochman R; Margalioth EJ; Eldar-Geva T; Gal M; Bdolah Y; Imbar T; Hurwitz A; Ben-Chetrit A; Goldberg D
    Gynecol Endocrinol; 2015 Oct; 31(10):779-82. PubMed ID: 26291805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.